Soluble Interleukin-2 Receptor Predicts Treatment Outcome in Patients With Autoimmune Tubulointerstitial Nephritis. A

Satoka Shiratori-Aso1, Daigo Nakazawa1, Saori Nishio1

  • 1Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Frontiers in Medicine
|March 14, 2022
PubMed
Abstract